FindTrial
Sign In

Probiotics Decrease the Occurence of Metabolic Disorders Under the Guidance of FMO3 Genotype After Liver Transplantation

Probiotics Decrease the Occurence of Metabolic Disorders Under the Guidance of FMO3 Genotype After Liver Transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018122
Enrollment
Unknown
Registered
2018-08-31
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

experimental group versus control group:Probiotics versus blank

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients underwent orthotopic liver transplantation; 2. Over the age of 18 years; 3. Known FMO3 rs2266782 genotype; 4. Be able to give informed consent; 5. Han nationality.

Exclusion criteria

Exclusion criteria: 1. Living donors.

Design outcomes

Primary

MeasureTime frame
blood glucose;blood pressure;lipid;BMI;—

Countries

China

Contacts

Public ContactJunwei Fan

Shanghai General Hospital

drjunweifan@163.com+86 13917865931

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026